“…In addition, a large subgroup of patients with comorbid PDs is excluded from PTSD treatment due to the common confluence of exclusion criteria for suicidality or self-destructive behaviour (American Psychological Association, 2017 ; National Collaborating Centre for Mental Health National Collaborating Centre for Mental Health, 2005 ). Ambiguity in the existing literature with regard to the impact of PDs on PTSD treatment outcome further complicates this issue: while some studies found an association between comorbid PDs and an enhanced risk for dropout (McDonagh et al, 2005 ) as well as a poorer response to treatment (Cloitre & Koenen, 2001 ; Forbes et al, 2002 ; Hembree, Cahill, & Foa, 2004 ; Stalker, Palmer, Wright, & Gebotys, 2005 ), other studies failed to find a relationship between PDs and PTSD treatment outcome (Clarke, Rizvi, & Resick, 2008 ; Feeny, Zoellner, & Foa, 2002 ; Markowitz et al, 2015 ; Tarrier, Sommerfield, Pilgrim, & Faragher, 2000 ; Van Minnen, Arntz, & Keijsers, 2002 ; Walter et al, 2012 ) and a recent meta-analysis concluded that PTSD interventions can be safe and effectively applied in patients with comorbid borderline PD (Slotema, Wilhelmus, Arends, & Franken, 2020 ). Given these inconsistencies, it remains unclear if and to what extent comorbid PDs affect the severity of PTSD symptoms and whether psychotherapies for PTSD can be just as effectively applied in patients with comorbid PDs as in patients without comorbid PDs.…”